8,528 reports of this reaction
2.0% of all HYDROXYCHLOROQUINE reports
#8 most reported adverse reaction
JOINT SWELLING is the #8 most commonly reported adverse reaction for HYDROXYCHLOROQUINE, manufactured by Chartwell RX, LLC. There are 8,528 FDA adverse event reports linking HYDROXYCHLOROQUINE to JOINT SWELLING. This represents approximately 2.0% of all 427,335 adverse event reports for this drug.
Patients taking HYDROXYCHLOROQUINE who experience joint swelling should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
JOINT SWELLING is a less commonly reported adverse event for HYDROXYCHLOROQUINE, but still significant enough to appear in the safety profile.
In addition to joint swelling, the following adverse reactions have been reported for HYDROXYCHLOROQUINE:
The following drugs have also been linked to joint swelling in FDA adverse event reports:
JOINT SWELLING has been reported as an adverse event in 8,528 FDA reports for HYDROXYCHLOROQUINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
JOINT SWELLING accounts for approximately 2.0% of all adverse event reports for HYDROXYCHLOROQUINE, making it a notable side effect.
If you experience joint swelling while taking HYDROXYCHLOROQUINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.